Goseki grade and tumour location influence survival of patients with gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1429-1434

  Calik, Muhammet ^a   Calik, Ilknur ^b   Demirci, Elif ^a   Altun, Eren ^a   Gundogdu, Betul ^a   Sipal, Sare ^a   Gundogdu, Cemal ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Education and Research Hospital ^*  (Turkey)

Author keywords

Gastric cancer; Goseki grade; Survival; Tumour location; Turkey

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLASSIFICATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; STOMACH TUMOR; SURVIVAL RATE; TREATMENT OUTCOME; TURKEY (REPUBLIC); VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TURKEY;

EID: 84896833110     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1429     Document Type: Article

References (29)

1. Bittoni A, Scartozzi M, Giampieri R, et al (2013). Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. PLoS One, 8, 78544.
2. Carl-McGrath S, Ebert M, Röcken C (2007). Gastric adenocarcinoma: epidemiology, pathology and pathogenesis. Cancer Therapy, 5, 877-94.
3. Deng J, Liang H, Sun D, et al (2010). The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res, 161, 47-53.
4. Dixon MF, Martin IG, Sue-Ling HM, et al (1994). Goseki grading in gastric cancer: comparison with existing systems of grading and its reproducibility. Histopathology, 25, 309-16.
5. Dolan K, Sutton R, Walker S.J, et al (1999) New classification of of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer, 80, 834-42.
6. Fontana MG, La Pinta M, Moneghini D, et al (2003). Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer, 88, 401-5.
7. Ghosh S, Ghosh TK, Dewasi N, Das K (2010) Prognostic information of gastric carcinoma using Goseki system in relation to nuclear organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA) expression. Bangladesh J Med Sci, 9, 76-86.
8. Goseki N, Takizawa T, Koike M (1992). Differences in the mode of extension of gastric cancer classified by histological types: new histological classification of gastric carcinoma. Gut, 33, 606-12.
9. Grunnet M, Mau-Sørensen M, Brünner N (2013). Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review. Scand J Gastroenterol, 48, 899-905.
10. Harrison LE, Karpeh MS, Brennan MF(1997). Proximal gastric cancers resected via a transabdominal-only approach. Ann Surg, 225, 678-85.
11. Holster IL, Aarts MJ, Tjwa ET, Lemmens VE, Kuipers EJ (2013). Trend breaks in incidence of non-cardia gastric cancer in the Netherlands. Cancer Epidemiol. ??.
12. Hu B, El Hajj N, Sittler S, et al (2012). Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol, 3, 251-61.
13. Ito H, Inoue H, Odaka N, et al (2013). Comparison of clinicopathological characteristics in the patients with cardiac cancer with or without esophagogastric junctional invasion: aSingle-Center Retrospective Cohort Study. Int J Surg Oncol, 2013, 189459.
14. Lee MH, Choi KS, Lee YY, et al (2013). Relationship between social network and stage of adoption of gastric cancer screening among the Korean population. Asian Pac J Cancer Prev, 14, 6095-101.
15. Martin IG, Dixon MF, Sue-Ling, et al (1994). Goseki histological grading of gastric cancer is an important predictor of outcome. Gut, 35, 758-63.
16. Michelassi F, Takanishi DM, Pantalone D, et al (1994) Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery, 116, 804-10.
17. Mills SA, Contos MJ, Goel R (2006). The stomach. In 'Silverberg's Principles and Practice of Surgical Pathology and Cytopathology', Eds Silverberg SG, DeLellis RA, Frable WJ, LiVolsi VA, Wick MR. 4th ed., PA, USA: Churchill Livingstone, Elsevier, Philadelphia, pp 1321-72.
18. Nagini S (2012). Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol, 4, 156-69.
19. Qiu MZ, Cai MY, Zhang DS, et al (2013). Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med, 11, 58.
20. Saha AK, Maitra S, Hazra SC (2013). Epidemiology of gastric cancer in the gangetic areas of west bengal. ISRN Gastroenterol, 2013, 823483
21. Sanchez-Bueno F, Garcia-Marcilla A, Perez-Flores D, et al (1998). Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg, 85, 255-60.
22. Song B, Duan ZY, Zhong YH, et al (2013). Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk, Asian Pac J Cancer Prev, 14, 6649-51.
23. Songun I, Van de Velde CJ, Arends JW, et al (1999) Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer, 85, 2114-8.
24. Talaiezadeh A, Hajiani E, Tarshizi MA (2013). The relative frequency of the Helicobacter pylori infection in proximal gastric cancers, Pol Przegl Chir, 85, 657-62.
25. Wang W, Li YF, Sun XW, et al (2010). Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer, 29, 923-30.
26. Washington K (2010). 7th edition of the AJCC cancer staging manual: Stomach. Ann Surg Oncol, 17, 3077-9.
27. Yalcin S (2009). Nutrition and gastric cancer in Turkey. Nutr Cancer, 61, 900-2.
28. Yalcin S (2009). Gastric cancer in Turkey-a bridge between west and East. Gastrointest Cancer Res, 3, 29-32.
29. Yu Q, Yu XF, Zhang SD, et al (2013). Prognostic role of c-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 5735-40.